EtiraRx

Dallas, United States

EtiraRx is a biopharmaceutical research firm that offers treatment for therapy-resistant metastatic breast cancer.

$2.4M raised

May 2026

Venture - Series Unknown

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about EtiraRx

How much funding has EtiraRx raised?

EtiraRx has raised $2.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2026.

Where is EtiraRx headquartered?

EtiraRx is headquartered in Dallas, United States.

What does EtiraRx do?

EtiraRx is a biopharmaceutical research firm that offers treatment for therapy-resistant metastatic breast cancer.

What stage is EtiraRx at?

EtiraRx is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 13, 2026.

MLA

"EtiraRx — Funding & Investors." VCBacked, May 13, 2026, https://www.vcbacked.co/company/etirarx. Accessed June 22, 2026.

APA

VCBacked. (2026). EtiraRx — Funding & Investors. Retrieved June 22, 2026, from https://www.vcbacked.co/company/etirarx

Wikipedia (cite web)

{{cite web |title=EtiraRx — Funding & Investors |url=https://www.vcbacked.co/company/etirarx |website=VCBacked |access-date=June 22, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 13, 2026.